Three further cases of babies falling ill after receiving feed made by Harlesden based company
ITH Pharma Limited is based in Premier Park Road, Harlesden (Pic credit: Google Streetview) - Credit: Archant
Three further cases of blood poisoning has been confirmed in babies who were fed contaminated batches of a food drip feed, developed by a Brent based pharmaceutical company.
The batch of intravenous liquid, called parenteral nutrition, thought to be responsible for this tragic incident, which resulted in the death of one baby, is manufactured by ITH Pharma Limited which is situated in Premier Park Road, Harlesden.
The babies affected, many of whom were deemed as premature and vulnerable, were treated neonatal intensive care units at hospitals in England, and given the feed direct to their bloodstream as they could not be fed by mouth.
The new report takes the total number of reported cases to 18.
The source of contamination remains a mystery.
You may also want to watch:
However, it is known that the blood poisoning was caused by a common bacterium known as Bacillus cereus –widely found in dust, soil and vegetation.
Public Health England claim while no new cases have occurred since 2 June 2014, when the batches of the affected stock expired, there is a possibility more cases to come.
Most Read
- 1 'It's heartbreaking': Volunteer slams Mayhew Animal Charity plans
- 2 Brent Council ordered to apologise and pay wheelchair user £27,000
- 3 'Unacceptable' failings in Met's handling of missing sisters
- 4 Who can get a Covid booster jab and how can I book one?
- 5 Derelict land in Kenton transformed by community bio diversity project
- 6 Brent's parks and gardens are big winners of London in Bloom awards
- 7 Women have access to free period packs in six Brent locations
- 8 QPR boss Warburton 'stunned' by Carabao Cup exit
- 9 Doctor fears another covid lockdown as vaccine take up 'wanes'
- 10 Brent residents invited to free Question Time event on climate change
The company has since launched a product recall to which the Medicines and Healthcare product Regulatory Agency (MHRA) has issued an alert to hospitals.
The MHRA is continuing its investigation into this incident and the manufacturer is co-operating fully.
